Literature DB >> 4564244

Suppression of adjuvant disease by bacterial extracellular products.

F Quagliata, A Taranta.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4564244      PMCID: PMC1005983          DOI: 10.1136/ard.31.6.500

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  16 in total

1.  Host-parasite relationships among group A streptococci. IV. Suppression of antibody response by streptococcal pyrogenic exotoxin.

Authors:  E E Hanna; D W Watson
Journal:  J Bacteriol       Date:  1968-01       Impact factor: 3.490

2.  Immunosuppressant from group A streptococci.

Authors:  A Malakian; J H Schwab
Journal:  Science       Date:  1968-02-23       Impact factor: 47.728

3.  Suppression of adjuvant arthritis by a new cytotoxic compound, rubidomycin.

Authors:  F Quagliata; P M Sanders; D L Gardner
Journal:  Ann Rheum Dis       Date:  1969-03       Impact factor: 19.103

4.  Competence of thoracic duct cells in the transfer of adjuvant disease and delayed hypersensitivity. Evidence that mycobacterial components are required for the successful transfer of the disease.

Authors:  F Quagliata; J M Phillips-Quagliata
Journal:  Cell Immunol       Date:  1972-01       Impact factor: 4.868

5.  Effect of prostaglandin E 1 on adjuvant arthritis.

Authors:  R B Zurier; F Quagliata
Journal:  Nature       Date:  1971-12-03       Impact factor: 49.962

6.  Competition of antigens in adjuvant disease of rats.

Authors:  I Gery; B H Waksman
Journal:  Arthritis Rheum       Date:  1967-06

7.  Effect of antilymphocytic antibody and antibody fragments on human lymphocytes in vitro.

Authors:  M F Woodruff; B Reid; K James
Journal:  Nature       Date:  1967-08-05       Impact factor: 49.962

8.  A sensitive hemagglutination assay method for dinitrophenyl-specific antibodies. The effect of antibody binding affinity on titers.

Authors:  B B Levine; V Levytska
Journal:  J Immunol       Date:  1967-03       Impact factor: 5.422

9.  Suppression of adjuvant disease in the rat by heterologous antilymphocyte globulin.

Authors:  H L Currey; M Ziff
Journal:  J Exp Med       Date:  1968-01-01       Impact factor: 14.307

10.  Dissociation of hemolytic and lymphocyte-transforming activities of streptolysin S preparations.

Authors:  A Taranta; G Cuppari; F Quagliata
Journal:  J Exp Med       Date:  1969-04-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Suppression of the immune response by microorganisms.

Authors:  J H Schwab
Journal:  Bacteriol Rev       Date:  1975-06

2.  Immunosuppressive activity of BCG: effects of adjuvant disease, lymphocyte subpopulations, and homing of thoracic duct cells in rats.

Authors:  R I Sutherland; M A Spadaro-Antonelli; V J Lawrence; F Quagliata
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

3.  Antiarthritic and immunosuppressive effects of Pseudomonas aeruginosa.

Authors:  G L Floersheim; J F Borel; D Wiesinger; J Brundell; Z Kis
Journal:  Agents Actions       Date:  1972

4.  Suppression of adjuvant disease by bacillus Calmette-Guérin (BCG).

Authors:  R I Sutherland; F Quagliata
Journal:  Experientia       Date:  1975-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.